maleimide has been researched along with sb 216763 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beller, M; Brennführer, A; Frech, MJ; Hübner, R; Jaster, R; Karapetyan, G; Ortinau, S; Pews-Davtyan, A; Rolfs, A; Schmöle, AC | 1 |
| Gao, M; Hutchins, GD; Miller, KD; Sledge, GW; Wang, M; Zheng, QH | 1 |
2 other study(ies) available for maleimide and sb 216763
| Article | Year |
|---|---|
Novel indolylmaleimide acts as GSK-3beta inhibitor in human neural progenitor cells.
Topics: beta Catenin; Cell Differentiation; Cell Proliferation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Maleimides; Neurons; Protein Kinase Inhibitors; Signal Transduction; Stem Cells; Wnt Proteins | 2010 |
The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3).
Topics: Carbon Radioisotopes; Glycogen Synthase Kinase 3; Indoles; Maleimides; Positron-Emission Tomography; Protein Kinase Inhibitors; Radiopharmaceuticals | 2011 |